I. W. Waters
University of Mississippi
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by I. W. Waters.
Life Sciences | 1980
W. Marvin Davis; Ronald F. Borne; Robert B. Hackett; I. W. Waters
Abstract The acute median lethal dose (LD50) was determined in rats (p.o.) and mice (i.p.) for phencyclidine (PCP) or 1-piperidinocyclohexanecarbonitrile (PCC) individually and in combination. The LD50 (mg/kg) of PCP was 2.3 or 2.5 times higher than the LD50 of PCC in mice or rats, respectively. For mice, combinations (8:1 or 4:1) of PCP + PCC showed additive synergism, while in rats a 2:1 combination caused sub-additive synergism. Dogs receiving an intravenous infusion of PCP + PCC (4:1) died at a one-third lower dosage of PCP than when PCP was given alone. Prior treatment with NaNO2 significantly elevated the i.p. LD50s in mice for PCC alone or PCP + PCC (3:1) as it did for KCN. These data support the inference that toxicity from PCC arises primarily from the cyanide ion which it releases. The possibility of a toxic synergism in the course of human exposure to PCC-contaminated “street PCP” is raised.
Toxicology | 1981
Robert B. Hackett; Keith W. Obrosky; Ronald F. Borne; I. W. Waters
Phencyclidine HCl was infused intravenously (1.0 mg/kg/min) to unanesthetized mongrel dogs until death. All animals experienced tonic-clonic convulsions (mean convulsive dose: 4.7 +/- 0.3 mg/kg) which lasted until shortly before death (mean lethal dose: 49.8 +/- 2.5 mg/kg). Significant increases in heart rate, arterial blood pressures, cardiac output, body temperature, and arterial pCO2 were observed in all animals. Significant reductions from pre-drug control values were observed in total peripheral resistance, arterial pH, arterial pO2, and respiratory minute volume. Blood lactate, oxygen uptake, and plasma glucose levels rose to values significantly higher than pre-drug control values then declined during the latter phase of the experiment, glucose levels decreased to final values lower than control. Animals appeared to die of primary respiratory failure, which was exacerbated by hyperthermia, and which resulted in final cardiovascular collapse.
Journal of Pharmacology and Experimental Therapeutics | 1981
John D. Catravas; I. W. Waters
Archives internationales de pharmacodynamie et de thérapie | 1978
John D. Catravas; I. W. Waters; Walz Ma; W.M. Davis
Journal of Medicinal Chemistry | 1984
Ronald F. Borne; E. Kim Fifer; I. W. Waters
Journal of Pharmacology and Experimental Therapeutics | 1977
John D. Catravas; I. W. Waters; John P. Hickenbottom; W.M. Davis
Journal of Pharmaceutical Sciences | 1974
Ronald F. Borne; Richard L. Peden; I. W. Waters; Myra Weiner; Robert Jordan
Journal of Medicinal Chemistry | 1987
Edward C. R. Smith; Thomas N. Riley; Ronald F. Borne; I. W. Waters
Journal of Medicinal Chemistry | 1973
Ronald F. Borne; Hassan Y. Aboul-Enein; I. W. Waters; Jennifer Hicks
Journal of Medicinal Chemistry | 1972
Ronald F. Borne; Richard L. Peden; I. W. Waters; Myra Weiner; Marjorie Walz